
Large and medium-sized Asian pharma manufacturers are constantly under pressure to produce high quality products on time. Economic fluctuations as well as compliance with strict legal requirements are causing manufacturers to face complex situations every day. Trying to minimize costs and make profits while maintaining the competitiveness is indeed very challenging. The best and utmost solution to increase efficiency at reduced costs is to digitize production processes by introducing a Manufacturing Execution System (MES) that will help address various issues at production level.
Pharma and biotech companies gain MES benefits from high quality control, reduced downtime and shop floor transparency as every manufacturing activity can be easily traced. As a result, the quality of production can be significantly improved. With the help of MES, it is easy to ensure that the manufactured products are produced as planned in a timely manner. Costs are kept down with efficient and cost-effective production, significantly improving performance of the organization and achieving profitable outcomes. Last but not least, when deciding to start an MES project, it is necessary to understand the benefits in all end-to-end manufacturing processes. Conducting a business benefit analysis can help identify the added values so that the investment for improving the efficiency of production processes will actually pay off.